High-cost-per-dose large molecules can make a big impact on cell and gene therapy supply chain management.
Matthew Lakelin, PhD
Advertisement
Articles by Matthew Lakelin, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
High-cost-per-dose large molecules can make a big impact on cell and gene therapy supply chain management.